Nurix Therapeutics OverviewNurix Therapeutics Other Income Expense Net
Other Income/Expense Net for NRIX.
Quarterly Other Income/Expense
$5.32M
↓ 18.3% YoY
As of Feb 28, 2026
Annual Other Income/Expense (TTM)
$20.78M
↓ 7.45% YoY
Trailing 12 months ending Feb 28, 2026